Sabadell Asset Management, S.A S.G.I.I.C Amgen Inc Transaction History
Sabadell Asset Management, S.A S.G.I.I.C
- $482 Billion
- Q2 2023
A detailed history of Sabadell Asset Management, S.A S.G.I.I.C transactions in Amgen Inc stock. As of the latest transaction made, Sabadell Asset Management, S.A S.G.I.I.C holds 4,930 shares of AMGN stock, worth $1.64 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
4,930
Previous 4,256
15.84%
Holding current value
$1.64 Million
Previous $1.08 Billion
2.87%
% of portfolio
0.23%
Previous 0.23%
Shares
7 transactions
Others Institutions Holding AMGN
# of Institutions
3,054Shares Held
409MCall Options Held
7.19MPut Options Held
6.26M-
Vanguard Group Inc Valley Forge, PA51.9MShares$17.2 Billion0.32% of portfolio
-
Black Rock Inc. New York, NY46MShares$15.3 Billion0.33% of portfolio
-
State Street Corp Boston, MA29MShares$9.63 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA14.4MShares$4.8 Billion3.32% of portfolio
-
Morgan Stanley New York, NY14.4MShares$4.77 Billion0.35% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $178B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...